期刊文献+

MMp-9、hsCRP与高血压合并2型糖尿病患者颈动脉硬化、肱动脉内皮功能的相关性研究 被引量:3

在线阅读 下载PDF
导出
摘要 目的:探讨基质金属蛋白酶-9(MMP-9)、超敏C-反应蛋白(hsCRP)与高血压合并2型糖尿病患者颈动脉硬化、肱动脉内皮功能的关系。方法:选择76例单纯高血压患者采用高分辨血管外超声法检测颈动脉内膜中层厚度(IMT)、粥样斑块及在静息、反应性充血时的肱动脉内径;用免疫学方法测定血清中MMP-9、hsCRP浓度。并以同样的方法观察高血压合并2型糖尿病的患者82例的上述指标。然后分析超声结果与血清MMP-9、hsCRP浓度的关系。结果:高血压合并2型糖尿病的患者IMT值、斑块发生率及MMP-9和hsCRP值明显高于单纯高血压患者,差异有显著性(P<0.05);MMP-9及hsCRP与高血压合并2型DM的患者IMT值、颈动脉斑块发生率呈正相关,r值分别为0.85,0.74,0.79,0.76;P<0.05。肱动脉内皮功能(Flow-MD)与血清中MMP-9、hsCRP浓度呈负相关,r值分别是-0.83,-0.88,差异有非常显著性(P<0.01)。结论:MMP-9及hsCRP在高血压合并2型糖尿病患者颈动脉粥样硬化发生发展过程中可能起重要作用。
出处 《中国医药导报》 CAS 2008年第2期39-40,共2页 China Medical Herald
  • 相关文献

参考文献11

  • 1[1]Ross R.Atherosclerosis:an inflammatory disease[J].N Engl J Med,1999,340:115-126.
  • 2[2]Ferroni P,Basili S,Loyhtya M,et al.Serum metalloproteinase -9 levels in patients with coronary artery disease:a novel marker of inflammation[J].J Invest Med,2003,51:295-300.
  • 3[3]Prisant LM.Diabetes mellitus and hypertension:a mandate forintense treatment according to new guidelines[J].American Journal of Therapeutics,2003,10:363-369.
  • 4[4]Jogestrand T,Fehrman Ekholm I,Angelin B,et al.Increased prevalence of atherosclerotic wall changes in patients with hyperlipidaemia after renal transplantation[J].J Intern Med,1996,239:177-180.
  • 5[5]Tetickovic E,Gajsek MM,Matela J,et al.Three dimensional ultrasonography for the evaluation of therosclerotic stenosis of the carotid trunk.[J].Coll Antropol,2001,25:511-520.
  • 6[6]O'leary DH,Polak JF,Kronmal RA,et al.Carotid artery intima and media thickness as a risk factor for yocardial infarction and stroke in older adults[J].N Engl J Med,1999,340:14-22.
  • 7[7]Celermajer DS,Sorensen KE,Gooch NM,et al.Non-invasive detection of endothelial dysfunction in child and adults at risk of atherosclerosis[J].Lancet,1992,340:1111-1115.
  • 8[8]Smeglin A,Frishman WH.Elastinolytic matrix metalloproteinases and their inhibitors as therapeutic targets in atherosclerotic[J].Cardiol Rev,2004,12:141-150.
  • 9[9]Wikstand J,Wiklund O.Frontiers in Cardiovascular Science:quantitative measurements of atherosclerotic manifestations in human[J].Arterioscler Thromb,1992,12:114-119.
  • 10罗莉,吴可贵.高血压合并糖尿病患者颈动脉内膜-中层厚度的观察[J].高血压杂志,2004,12(6):512-514. 被引量:11

二级参考文献6

  • 1Assmann G,Schulte H. The prospective cardiovascular munster(PROCAM) study: preralence of hyperlipidemia in patients with hypertension and diadetes mellitus and relationship to coronary heart disease[J].Am Heart J,1998,116:1713.
  • 2Lakka TA, Lakka HM, Salonen R. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men[J].Atheroslerosis,2001,154:479.
  • 3Magyar MT, Paragh G, Katona E, et al. Serum cholesterols have a more important role than triglycerides in determining intima-media thickness of the common carotid artery in subjects younger than 55 years of age[J].J ultrasound Med,2004,23:1161-1169
  • 4Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial[J].Lancet,2004,364:685-696.
  • 5Haffner SM, Agostino RD Jr, Saad MF, et al. carotid artery atherosclerosis in type 2 diabetic and nondiabetic subjects with and without symptomatic coronary artery disease (The Insulin Resistance Atheroslerosis Study)[J].Am J Cardiol,2000,85:1395.
  • 6周君毅,刘玉山,甄永存.彩色多普勒在糖尿病患者下肢动脉粥样硬化诊断中的应用[J].中国医学影像技术,2001,17(5):469-470. 被引量:39

共引文献10

同被引文献23

  • 1魏丽,贾伟平,吴海娅,陆俊茜,包玉倩,陆惠娟,潘晓平,项坤三.肥胖及2型糖尿病患者血清apelin水平及其相关因素分析[J].中华内分泌代谢杂志,2007,23(2):130-133. 被引量:39
  • 2Jefferson JA,Shankland SJ,Pichler RH.Proteinuria in diabetic kidney disease:a mechanistic view point.Kidney In t,2008,74:22-36.
  • 3Xiang GD,Xu L,Zhao LS,et al.The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes.Diabetes,2006,55:2126-2131.
  • 4American Diabetes Association.Diabetic nephropathy.Position statement.Diabetes Care,2003,26(Suppl 1):S94-98.
  • 5Ruggenenti P,Craved P,Remuzzi G,et al.The RAAS in the pathogenesis and treatmemt of diabetic nephropathy.Nat Rev Nephrol,2010,6:319-330.
  • 6Deckert T.Nephropathy and coronary death:the fatal twins in diabetes mellitus.Nephrol Dial Transplant,1994,9:1069-1071.
  • 7Jensen T,Bjerre-Knudsen J,Feldt-Rasmussen B,et al.Features of endothelial dysfunction in early diabetic nephropathy.Lancet,1989,1:461-463.
  • 8Martin I.Implementation of WHO/ISH Guidelines: role and activities of WHO[J].Clinical and experimental hypertension,1999,21(5/6):659-669.
  • 9Ichard JL,Sultan A,Daures JP,et al.Diagnosis of diabetes mellitus and intermediate glucose abnormalities in obese patients based on ADA (1997) and WHO (1985) criteria[J].Diabetie medicine,2002,19(4):292-299.
  • 10高明杰,华扬,贾凌云等.糖尿病合并高血压与单纯糖尿病患者大血管病变差异性的研究分析[c].2012中国·北京超声医学学术大会论文集.北京:中国医师协会超声医师分会,2012:397-398.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部